WuXi AppTec Co. Ltd (WX8) - Total Assets
Based on the latest financial reports, WuXi AppTec Co. Ltd (WX8) holds total assets worth €83.82 Billion EUR (≈ $98.00 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See WX8 net asset value for net asset value and shareholders' equity analysis.
WuXi AppTec Co. Ltd - Total Assets Trend (2016–2024)
This chart illustrates how WuXi AppTec Co. Ltd's total assets have evolved over time, based on quarterly financial data.
WuXi AppTec Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
WuXi AppTec Co. Ltd's total assets of €83.82 Billion consist of 48.2% current assets and 51.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 22.8% |
| Accounts Receivable | €7.95 Billion | 9.9% |
| Inventory | €5.40 Billion | 6.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.57 Billion | 2.0% |
| Goodwill | €972.35 Million | 1.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how WuXi AppTec Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see WX8 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: WuXi AppTec Co. Ltd's current assets represent 48.2% of total assets in 2024, a decrease from 57.0% in 2016.
- Cash Position: Cash and equivalents constituted 22.8% of total assets in 2024, down from 23.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 5.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 9.9% of total assets.
WuXi AppTec Co. Ltd Competitors by Total Assets
Key competitors of WuXi AppTec Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
WuXi AppTec Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.08 | 2.22 | 3.26 |
| Quick Ratio | 1.73 | 1.83 | 2.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €22.07 Billion | €16.61 Billion | €16.64 Billion |
WuXi AppTec Co. Ltd - Advanced Valuation Insights
This section examines the relationship between WuXi AppTec Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.49 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 9.0% |
| Total Assets | €80.33 Billion |
| Market Capitalization | $8.77 Billion USD |
Valuation Analysis
Below Book Valuation: The market values WuXi AppTec Co. Ltd's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: WuXi AppTec Co. Ltd's assets grew by 9.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for WuXi AppTec Co. Ltd (2016–2024)
The table below shows the annual total assets of WuXi AppTec Co. Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €80.33 Billion ≈ $93.91 Billion |
+9.04% |
| 2023-12-31 | €73.67 Billion ≈ $86.13 Billion |
+13.88% |
| 2022-12-31 | €64.69 Billion ≈ $75.63 Billion |
+17.35% |
| 2021-12-31 | €55.13 Billion ≈ $64.45 Billion |
+19.09% |
| 2020-12-31 | €46.29 Billion ≈ $54.12 Billion |
+58.32% |
| 2019-12-31 | €29.24 Billion ≈ $34.18 Billion |
+28.99% |
| 2018-12-31 | €22.67 Billion ≈ $26.50 Billion |
+80.18% |
| 2017-12-31 | €12.58 Billion ≈ $14.71 Billion |
+18.79% |
| 2016-12-31 | €10.59 Billion ≈ $12.38 Billion |
-- |
About WuXi AppTec Co. Ltd
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manuf… Read more